From the early days of culture, humans have known that too much of anything is good for nothing.

Having the tough conversations is important.

NervGen Pharma Corp., a clinical stage biotech company dedicated to creating innovative solutions for the treatment of nervous system damage, announced today it has entered into a research collaboration with Dr. Ksenia Kastanenka of Massachusetts General Hospital (MGH) to study the effects of NervGen's lead compound, NVG-291, in validated animal models of Alzheimer's disease.

Health officials from throughout the world, including right here in the Las Vegas valley, are discussing the possibility of a third COVID shot.

Class begins bright and early Monday morning for more than 300,000 Clark County School District students.

There is something uniquely human about the positive feelings we all experience when we do something good for someone else.

Zero-commission brokerage Robinhood Financial’s business model could take a hit if the Securities and Exchange Commission treats the firm’s communications with its customers as investment advice, according to legal experts.

Experts say the question is acceptable – even advisable – in everyday interactions, though you might not get an answer.